EMBOLIC CEREBELLAR INFARCTION

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting EMBOLIC CEREBELLAR INFARCTION:

# Drug Count
0 EMPAGLIFLOZIN 6
1 GLIMEPIRIDE 6
2 SERTRALINE 6
3 SITAGLIPTIN 6
4 METFORMIN 5
5 METFORMIN ER 500 MG 5
6 METFORMIN ER 750 MG 5
7 NIVOLUMAB 3
8 AXITINIB 2
9 CISPLATIN 2
See all common drugs associated with EMBOLIC CEREBELLAR INFARCTION

EMBOLIC CEREBELLAR INFARCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAPLACIZUMAB 1 0.0006
1 DAPRODUSTAT 1 0.0005
2 PYRIDOSTIGMINE BROMIDE 2 0.0003
3 ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE 1 0.0002
4 GLIMEPIRIDE 6 0.0002
5 CILTACABTAGENE AUTOLEUCEL 1 0.0002
6 EDOXABAN TOSYLATE 1 0.0001
7 PHYTONADIONE 1 0.0001
8 AXITINIB 2 0.0001
9 EMPAGLIFLOZIN 6 0.0001
See all drugs enriched for association with EMBOLIC CEREBELLAR INFARCTION